Lisata Therapeutics Acquires Marea Therapeutics in Strategic Merger
Acquiring Company
Lisata Therapeutics
Acquired Company
Marea Therapeutics
CincinnatiSan FranciscoBiotechnologyHealth CareTherapeuticsPharmaceuticalBiotechnologyTherapeuticsDescription
On September 17, 2026, Lisata Therapeutics, Inc. acquired Marea Therapeutics, Inc. as part of a strategic merger. This transaction involved the merger of First Merger Sub with and into Marea, resulting in Marea becoming a wholly owned subsidiary of Lisata. This acquisition is expected to enhance Lisata's therapeutic development capabilities.
Don't miss Lisata Therapeutics's next move
Get an email the moment Lisata Therapeutics makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
M&A Insights
Based on deal dataFrequently asked
Who acquired Marea Therapeutics?
Marea Therapeutics was acquired by Lisata Therapeutics, based in Cincinnati. The deal was reported on September 17, 2026. Lisata Therapeutics Inc (NASDAQ:LSTA) is a pharmaceutical company that is partnering with the University of Cincinnati to investigate endometriosis therapy. Lisata Therapeutics is publicly traded (LSTA) and operates in Biotechnology.
When did Lisata Therapeutics acquire Marea Therapeutics?
Lisata Therapeutics's acquisition of Marea Therapeutics was reported on September 17, 2026. On September 17, 2026, Lisata Therapeutics, Inc. acquired Marea Therapeutics, Inc. as part of a strategic merger. This transaction involved the merger of First Merger Sub with and into Marea, resulting in Marea becoming a wholly owned subsidiary of Lisata. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Marea Therapeutics do?
Marea Therapeutics is a clinical-stage biotechnology company focused on developing a new generation of medicines for cardiometabolic diseases. It is privately held, operating in Biotechnology, and is based in San Francisco.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.